Status:
UNKNOWN
Dose of Remimazolam in Children for Intubation
Lead Sponsor:
Zhihong LU
Conditions:
Anesthesia
Eligibility:
All Genders
3-12 years
Phase:
NA
Brief Summary
Remimazolam has demonstrated the potential as a valuable medication for procedural sedation and general anesthesia. However, half effective dose of remimazolam required to prevent cardiovascular respo...
Eligibility Criteria
Inclusion
- age from 3 to 12 years old
- patients scheduled for surgery under general anesthesia
- Body mass index in the range of 5% -95% of the same age group
- Consent was obtained from the patient and the family members, and an informed consent form was signed
Exclusion
- American Society of Anesthesiologists status ≥3
- patients who cannot cooperate with intravenous anesthesia induction
- patients with risk of difficult airway
- patients who are allergic to benzodiazepines
- patients with neurological dysfunction
- Participate involved in other clinical investigators within 3 months
Key Trial Info
Start Date :
December 20 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06170918
Start Date
December 20 2023
End Date
May 31 2024
Last Update
December 14 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.